Company intelligence / Profile preview
Inventera Pharmaceutical Co Ltd
Seoul, Seoul, South Koreainventera.kr ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Inventera specializes in developing advanced diagnostic imaging contrast agents, including nanoparticles for MR liver imaging. Its pipeline includes products in preclinical through Phase 2 stages targeting cardiovascular, digestive, nervous system, orthopedic/joint, and lymphatic diseases. Some programs have reached early clinical phases with ongoing development of both medical devices and radiopharmaceuticals. No commercialized products yet identified as of the latest updates.[2][3][4]
- Therapeutic areas
- HematologyRheumatologyGastroenterologyCardiovascularNeurology
- Modalities
- Contrast agentsDiagnostic radiopharmaceuticalsNanoparticles (for imaging)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Inventera Pharmaceutical Co Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inventera Pharmaceutical Co Ltd.